A Phase I Study of a DNA Vaccine Encoding Androgen Receptor Ligand-Binding Domain (AR LBD) +/-GMCSF

NCT02411786 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
40
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

University of Wisconsin, Madison

Collaborators